• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期乳腺癌的保守治疗:导管原位癌成分及其他病理变量对局部控制和生存的预后价值。长期结果

Conservative treatment of early breast cancer: prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-term results.

作者信息

Zafrani B, Vielh P, Fourquet A, Mosseri V, Durand J C, Salmon R J, Vilcoq J R

机构信息

Department of Pathology, Institut Curie, Paris, France.

出版信息

Eur J Cancer Clin Oncol. 1989 Nov;25(11):1645-50. doi: 10.1016/0277-5379(89)90311-8.

DOI:10.1016/0277-5379(89)90311-8
PMID:2556282
Abstract

Four hundred and thirty-four patients with infiltrative ductal carcinoma were treated by limited surgery and irradiation between January 1960 and December 1980. The median follow-up was 103 months. Retrospective pathological analysis of the primary tumor identified a subset of pathological parameters which were predictors of local breast failure and survival. Pathological predictors of local breast recurrence were: incomplete surgical excision (P less than 0.0001), lymphatic invasion (P less than 0.02) and presence of an extensive in situ component (EDISC) (P less than 0.03). Pathological predictors of survival were: incomplete surgery (P less than 0.007), size of the primary tumour (P less than 0.03), high histologic grade (P less than 0.005), lymphatic invasion (P less than 0.0001) and absence of associated in situ component (P less than 0.008). This study emphasizes the role of the in situ component in the prognosis of breast carcinoma treated with conservative management.

摘要

1960年1月至1980年12月期间,434例浸润性导管癌患者接受了局部手术和放疗。中位随访时间为103个月。对原发肿瘤进行回顾性病理分析,确定了一组病理参数,这些参数是局部乳腺失败和生存的预测指标。局部乳腺复发的病理预测指标为:手术切除不完整(P<0.0001)、淋巴管侵犯(P<0.02)和广泛原位成分(EDISC)的存在(P<0.03)。生存的病理预测指标为:手术不完整(P<0.007)、原发肿瘤大小(P<0.03)、高组织学分级(P<0.005)、淋巴管侵犯(P<0.0001)和无相关原位成分(P<0.008)。本研究强调了原位成分在保守治疗乳腺癌预后中的作用。

相似文献

1
Conservative treatment of early breast cancer: prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-term results.早期乳腺癌的保守治疗:导管原位癌成分及其他病理变量对局部控制和生存的预后价值。长期结果
Eur J Cancer Clin Oncol. 1989 Nov;25(11):1645-50. doi: 10.1016/0277-5379(89)90311-8.
2
Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment.采用保乳手术和根治性放疗治疗的乳腺导管原位癌(导管内癌)。病理参数与治疗结果的相关性。
Cancer. 1993 Apr 15;71(8):2532-42. doi: 10.1002/1097-0142(19930415)71:8<2532::aid-cncr2820710817>3.0.co;2-0.
3
Factors influencing local recurrence after excision and radiotherapy for primary breast cancer.影响原发性乳腺癌切除术后及放疗后局部复发的因素。
Br J Surg. 1989 Sep;76(9):890-4. doi: 10.1002/bjs.1800760906.
4
Management of screen detected ductal carcinoma in situ of the female breast.
Br J Surg. 1989 Jun;76(6):564-7. doi: 10.1002/bjs.1800760612.
5
Breast carcinoma in situ.
Arch Surg. 1989 Jan;124(1):33-6. doi: 10.1001/archsurg.1989.01410010039008.
6
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.应用USC/范纽斯预后指数的259例乳腺导管原位癌患者:长期随访的回顾性研究
Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9.
7
Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.经乳房钼靶检查发现、临床隐匿的导管原位癌,采用保乳手术及根治性乳房放疗进行治疗。
Cancer J Sci Am. 1996 May-Jun;2(3):158-65.
8
Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.导管原位癌保守手术及放疗后的局部复发:家族史的潜在重要性
Cancer J Sci Am. 1995 May-Jun;1(1):55-61.
9
The impact of tumor size and histology on local control after breast-conserving therapy.保乳治疗后肿瘤大小和组织学对局部控制的影响。
Radiother Oncol. 1988 Apr;11(4):297-303. doi: 10.1016/0167-8140(88)90200-9.
10
Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy.乳腺导管内癌:保乳治疗患者局部复发相关的病理特征
Am J Surg Pathol. 2000 Aug;24(8):1058-67. doi: 10.1097/00000478-200008000-00003.

引用本文的文献

1
Extensive intraductal component as a factor determining local recurrence of breast cancer: a systematic review and meta-analysis.广泛导管内成分作为决定乳腺癌局部复发的一个因素:一项系统评价和荟萃分析
Gland Surg. 2023 Oct 30;12(10):1336-1347. doi: 10.21037/gs-23-137. Epub 2023 Oct 26.
2
[Oncoplastie with breast conservation in breast cancer treatment: about 16 cases].[乳腺癌治疗中保乳手术的肿瘤整形术:约16例]
Pan Afr Med J. 2015 Feb 27;20:180. doi: 10.11604/pamj.2015.20.180.4897. eCollection 2015.
3
Standardized and reproducible methodology for the comprehensive and systematic assessment of surgical resection margins during breast-conserving surgery for invasive breast cancer.
用于浸润性乳腺癌保乳手术中手术切缘综合系统评估的标准化且可重复的方法。
BMC Cancer. 2009 Jul 27;9:254. doi: 10.1186/1471-2407-9-254.
4
The distribution of lesions in 1-14-mm invasive breast carcinomas and its relation to metastatic potential.1 - 14毫米浸润性乳腺癌中病灶的分布及其与转移潜能的关系。
Virchows Arch. 2009 Aug;455(2):109-15. doi: 10.1007/s00428-009-0808-9. Epub 2009 Jul 21.
5
A review of current practices in breast conservation surgery in the UK.英国保乳手术当前实践的综述。
Ann R Coll Surg Engl. 2007 Mar;89(2):118-23. doi: 10.1308/003588407X155473.
6
Breast conservative therapy in east part of China: a retrospective cohort study.中国东部地区的保乳治疗:一项回顾性队列研究。
J Cancer Res Clin Oncol. 2006 Sep;132(9):573-8. doi: 10.1007/s00432-006-0104-x. Epub 2006 Jun 2.
7
Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients.适合保乳治疗的乳腺癌患者的对比增强磁共振成像:对患者亚组的补充价值
Eur Radiol. 2006 Mar;16(3):692-701. doi: 10.1007/s00330-005-0043-y. Epub 2005 Nov 19.
8
Core biopsy as a tool in planning the management of invasive breast cancer.核心活检作为规划浸润性乳腺癌治疗方案的一种工具。
World J Surg Oncol. 2005 Jan 4;3(1):1. doi: 10.1186/1477-7819-3-1.
9
Local Recurrence after Conservative Surgery for Breast Cancer.
Breast Cancer. 1996 Jun 28;3(2):135-139. doi: 10.1007/BF02966975.
10
Pathologic Assessment of Surgical Margins on Frozen and Permanent Sections in Breast Conserving Surgery.保乳手术中冰冻切片和石蜡切片手术切缘的病理评估
Breast Cancer. 1995 Apr 30;2(1):27-33. doi: 10.1007/BF02966893.